137 related articles for article (PubMed ID: 10337454)
41. Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats.
Koc A; Duru M; Ciralik H; Akcan R; Sogut S
Mol Cell Biochem; 2005 Oct; 278(1-2):79-84. PubMed ID: 16180092
[TBL] [Abstract][Full Text] [Related]
42. Gemifloxacin: effects of sub-inhibitory concentrations on various factors affecting bacterial virulence.
Dal Sasso M; Culici M; Bovio C; Braga PC
Int J Antimicrob Agents; 2003 Apr; 21(4):325-33. PubMed ID: 12672578
[TBL] [Abstract][Full Text] [Related]
43. [Simultaneous determination of erdosteine and its active metabolite in human plasma by liquid chromatography-tandem mass spectrometry with pre-column derivatization].
Jin J; Chen XY; Zhang YF; Ma ZY; Zhong DF
Yao Xue Xue Bao; 2013 Mar; 48(3):395-400. PubMed ID: 23724654
[TBL] [Abstract][Full Text] [Related]
44. Protective effect of erdosteine against cisplatin-induced ototoxicity in a guinea pig model.
Waissbluth S; Dupuis I; Daniel SJ
Otolaryngol Head Neck Surg; 2012 Apr; 146(4):627-32. PubMed ID: 22051542
[TBL] [Abstract][Full Text] [Related]
45. Regulation of sepsis-induced apoptosis of pulmonary cells by posttreatment of erdosteine and N-aceylcysteine.
Demiralay R; Gürsan N; Erdem H
Toxicology; 2006 Dec; 228(2-3):151-61. PubMed ID: 17046137
[TBL] [Abstract][Full Text] [Related]
46. Effects of erdosteine on hemostasis: an experimental study.
Tutanc M; Arica V; Motor S; Basarslan F; Erden ES; Ozturk OH; Zararsiz I; Aydin M
Hum Exp Toxicol; 2012 Jun; 31(6):574-8. PubMed ID: 22045892
[TBL] [Abstract][Full Text] [Related]
47. Protective effects of erdosteine and vitamins C and E combination on ischemia-reperfusion-induced lung oxidative stress and plasma copper and zinc levels in a rat hind limb model.
Sirmali M; Uz E; Sirmali R; Kilbaş A; Yilmaz HR; Altuntaş I; Naziroğlu M; Delibaş N; Vural H
Biol Trace Elem Res; 2007 Jul; 118(1):43-52. PubMed ID: 17848730
[TBL] [Abstract][Full Text] [Related]
48. Changes in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: a controlled study in current smokers with mild COPD.
Dal Negro RW; Visconti M; Micheletto C; Tognella S
Pulm Pharmacol Ther; 2008; 21(2):304-8. PubMed ID: 17889580
[TBL] [Abstract][Full Text] [Related]
49. Influence of subinhibitory concentrations of brodimoprim and trimethoprim on the adhesiveness, hydrophobicity, hemagglutination and motility of Escherichia coli.
Braga PC; Dal Sasso M; Maci S; Reggio S; Piatti G
Chemotherapy; 1995; 41(1):50-8. PubMed ID: 7875023
[TBL] [Abstract][Full Text] [Related]
50. Effect of metabolite I of erdosteine on the release of human neutrophil elastase.
Braga PC; Dal Sasso M; Culici M; Verducci P; Lo Verso R; Marabini L
Pharmacology; 2006; 77(3):150-4. PubMed ID: 16825803
[TBL] [Abstract][Full Text] [Related]
51. Hypobaric-hypoxia-induced pulmonary damage in rats ameliorated by antioxidant erdosteine.
Uzun O; Balbay O; Comunoğlu NU; Yavuz O; Nihat Annakkaya A; Güler S; Silan C; Erbaş M; Arbak P
Acta Histochem; 2006; 108(1):59-68. PubMed ID: 16537087
[TBL] [Abstract][Full Text] [Related]
52. Staphylococcus aureus and Escherichia coli adhesion to human cells is reduced by sub-MICs of gemifloxacin.
Braga PC; Dal SM; Woodnutt G
J Chemother; 2002 Feb; 14(1):41-6. PubMed ID: 11892898
[TBL] [Abstract][Full Text] [Related]
53. Inhibitory effect of N-acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro.
Riise GC; Qvarfordt I; Larsson S; Eliasson V; Andersson BA
Respiration; 2000; 67(5):552-8. PubMed ID: 11070462
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the effects of erdosteine and N-acetylcysteine on apoptosis regulation in endotoxin-induced acute lung injury.
Demiralay R; Gürsan N; Ozbilim G; Erdogan G; Demirci E
J Appl Toxicol; 2006; 26(4):301-8. PubMed ID: 16489578
[TBL] [Abstract][Full Text] [Related]
55. Erdosteine improves oxidative damage in a rat model of renal ischemia-reperfusion injury.
Gurel A; Armutcu F; Cihan A; Numanoglu KV; Unalacak M
Eur Surg Res; 2004; 36(4):206-9. PubMed ID: 15263825
[TBL] [Abstract][Full Text] [Related]
56. Effects of Erdosteine on Experimental Acute Pancreatitis Model.
Karapolat B; Karapolat S; Gurleyik E; Yasar M
J Coll Physicians Surg Pak; 2017 Oct; 27(10):606-610. PubMed ID: 29056120
[TBL] [Abstract][Full Text] [Related]
57. Erdosteine for COPD exacerbations.
Drug Ther Bull; 2008 Oct; 46(10):79-80. PubMed ID: 18832259
[TBL] [Abstract][Full Text] [Related]
58. Thiol-Based Drugs in Pulmonary Medicine: Much More than Mucolytics.
Cazzola M; Calzetta L; Page C; Rogliani P; Matera MG
Trends Pharmacol Sci; 2019 Jul; 40(7):452-463. PubMed ID: 31147200
[TBL] [Abstract][Full Text] [Related]
59. The effects of erdosteine, N-acetylcysteine and vitamin E on nicotine-induced apoptosis of cardiac cells.
Demiralay R; Gürsan N; Erdem H
J Appl Toxicol; 2007; 27(3):247-54. PubMed ID: 17216608
[TBL] [Abstract][Full Text] [Related]
60. A controlled multicenter pediatric study in the treatment of acute respiratory tract diseases with the aid of a new specific compound, erdosteine (IPSE, Italian Pediatric Study Erdosteine).
Titti G; Lizzio A; Termini C; Negri P; Fazzio S; Mancini C
Int J Clin Pharmacol Ther; 2000 Aug; 38(8):402-7. PubMed ID: 10984014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
